NDC properties for NDC 9 0641-6118
NDC item 00641611801
| NDC 9 | 0641-6118 |
|---|---|
| NDC 10 | 0641-6118-01 |
| NDC Item | 00641611801 |
| packaging | 100 mL in 1 VIAL, PHARMACY BULK PACKAGE (0641-6118-01) |
| ANDA | ANDA065403 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-03 |
| Marketing status | ACTIVE |
NDC item 00781303446
| NDC 9 | 0781-3034 |
|---|---|
| NDC 10 | 0781-3034-46 |
| NDC Item | 00781303446 |
| packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PHARMACY BULK PACKAGE (0781-3034-46) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | DROPPED |
NDC item 25021014499
| NDC 9 | 25021-144 |
|---|---|
| NDC 10 | 25021-144-99 |
| NDC Item | 25021014499 |
| packaging | 1 BOTTLE in 1 CARTON (25021-144-99) / 100 mL in 1 BOTTLE |
| ANDA | ANDA065403 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-08-12 |
| Marketing status | ACTIVE |
NDC item 25021018899
| NDC 9 | 25021-188 |
|---|---|
| NDC 10 | 25021-188-99 |
| NDC Item | 25021018899 |
| packaging | 1 BOTTLE in 1 CARTON (25021-188-99) / 100 mL in 1 BOTTLE |
| ANDA | ANDA090578 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
NDC item 44567021201
| NDC 9 | 44567-212 |
|---|---|
| NDC 10 | 44567-212-01 |
| NDC Item | 44567021201 |
| packaging | 1 VIAL in 1 CARTON (44567-212-01) / 100 mL in 1 VIAL |
| ANDA | ANDA065188 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-25 |
| Marketing status | ACTIVE |
NDC item 55150011801
| NDC 9 | 55150-118 |
|---|---|
| NDC 10 | 55150-118-01 |
| NDC Item | 55150011801 |
| packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-118-01) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA090339 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
NDC item 55150011899
| NDC 9 | 55150-118 |
|---|---|
| NDC 10 | 55150-118-99 |
| NDC Item | 55150011899 |
| packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-118-99) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA090339 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
NDC item 63323037062
| NDC 9 | 63323-370 |
|---|---|
| NDC 10 | 63323-370-62 |
| NDC Item | 63323037062 |
| packaging | 10 VIAL in 1 CARTON (63323-370-62) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065314 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-11-27 |
| Marketing status | COMPLETED |
NDC item 66794020815
| NDC 9 | 66794-208 |
|---|---|
| NDC 10 | 66794-208-15 |
| NDC Item | 66794020815 |
| packaging | 1 BOTTLE in 1 CARTON (66794-208-15) / 100 mL in 1 BOTTLE |
| ANDA | ANDA090578 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
NDC item 66794024315
| NDC 9 | 66794-243 |
|---|---|
| NDC 10 | 66794-243-15 |
| NDC Item | 66794024315 |
| packaging | 1 BOTTLE in 1 CARTON (66794-243-15) / 100 mL in 1 BOTTLE |
| ANDA | ANDA090578 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-05-20 |
| Marketing status | COMPLETED |
NDC item 67457064910
| NDC 9 | 67457-649 |
|---|---|
| NDC 10 | 67457-649-10 |
| NDC Item | 67457064910 |
| packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (67457-649-10) / 92 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA202197 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
NDC item 70594008301
| NDC 9 | 70594-083 |
|---|---|
| NDC 10 | 70594-083-01 |
| NDC Item | 70594008301 |
| packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70594-083-01) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA090578 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
NDC item 71288000775
| NDC 9 | 71288-007 |
|---|---|
| NDC 10 | 71288-007-75 |
| NDC Item | 71288000775 |
| packaging | 1 BOTTLE in 1 CARTON (71288-007-75) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090578 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2018-12-17 |
| Marketing status | COMPLETED |
NDC item 71288003375
| NDC 9 | 71288-033 |
|---|---|
| NDC 10 | 71288-033-75 |
| NDC Item | 71288003375 |
| packaging | 1 BOTTLE in 1 CARTON (71288-033-75) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA065314 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-11-27 |
| Marketing status | ACTIVE |
NDC item 71288003391
| NDC 9 | 71288-033 |
|---|---|
| NDC 10 | 71288-033-91 |
| NDC Item | 71288003391 |
| packaging | 1 BOTTLE in 1 CARTON (71288-033-91) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA065314 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-11-27 |
| Marketing status | ACTIVE |
NDC item 72485041801
| NDC 9 | 72485-418 |
|---|---|
| NDC 10 | 72485-418-01 |
| NDC Item | 72485041801 |
| ANDA | ANDA202197 |
| COLORTEXT | white(White to off-white dry powder) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-05-01 |
| Marketing status | ACTIVE |
NDC item 72485041815
| NDC 9 | 72485-418 |
|---|---|
| NDC 10 | 72485-418-15 |
| NDC Item | 72485041815 |
| packaging | 1 BOTTLE in 1 CARTON (72485-418-15) / 15 g in 1 BOTTLE |
| ANDA | ANDA202197 |
| COLORTEXT | white(White to off-white dry powder) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-05-01 |
| Marketing status | ACTIVE |
NDC item 72603044401
| NDC 9 | 72603-444 |
|---|---|
| NDC 10 | 72603-444-01 |
| NDC Item | 72603044401 |
| packaging | 10 BOTTLE in 1 CARTON (72603-444-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA065314 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
NDC item 82449051601
| NDC 9 | 82449-516 |
|---|---|
| NDC 10 | 82449-516-01 |
| NDC Item | 82449051601 |
| packaging | 1 BOTTLE in 1 CARTON (82449-516-01) / 15 g in 1 BOTTLE |
| ANDA | ANDA202197 |
| COLORTEXT | white(White to off-white dry powder) |
| Color | C48325 __ |
| Labeler | STERISCIENCE SPECIALTIES PRIVATE LIMITED |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-05-01 |
| Marketing status | ACTIVE |
NDC item 83634010899
| NDC 9 | 83634-108 |
|---|---|
| NDC 10 | 83634-108-99 |
| NDC Item | 83634010899 |
| packaging | 1 BOTTLE in 1 CARTON (83634-108-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA065314 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |